Accord Healthcare Adds Pemetrexed Lyo. Injection to Generic Drug Portfolio

DURHAM, N.C., May 27, 2022 -- (Healthcare Sales & Marketing Network) -- Accord Healthcare, Inc., a leading generic pharmaceutical company, has added Pemetrexed Lyo. Injection to its line of chemotherapy drugs. The new drug is formulated as a sterile lyoph... Biopharmaceuticals, Generics, Oncology Accord Healthcare, pemetrexed, ALIMTA , NSCLC
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news